DISARM Clinical Study B: Evaluation of Innovative Ovarian Cancer Biomarker Assays
18h agoen
From the article
Conditions : Ovarian Cancer Interventions : Diagnostic Test: Investigational ovarian cancer biomarker assays Sponsors : National and Kapodistrian University of Athens; European Commission Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read

Una nueva terapia logra atacar el cáncer de ovario reduciendo el daño a las células sanas
Infobae·3d ago
Ovarian cancer drug mirvetuximab improves quality of life for patients, UK women report
A new ovarian cancer drug called mirvetuximab is offering women more time and a better quality of life compared to standard chemotherapy. Pa
CRIS Contra el Cáncer financia una nueva estrategia de terapias dirigidas frente al cáncer de ovario
Infobae·3d ago
BMJ Research Article: Ovarian Cancer Diagnosis After Emergency Admission — Metadata Page
This appears to be a metadata/landing page for a BMJ research article about ovarian cancer diagnosis within 28 days after emergency hospital

Comments
Sign in to join the conversation.
No comments yet. Be the first.